Read articles from Global

May 21, 2025 by rstreet.org

Safer Solutions: Common Ground on Harm Reduction in Drugs and Tobacco

Text advocates for collaboration in harm reduction for drug and tobacco use. Both groups face addiction, health risks, and stigmas. Support for harm reduction tools like syringe programs and e-cigarettes can improve health outcomes. Political divides, misinformation, and discomfort hinder progress. Bridging the gap and recognizing commonalities could lead to a more effective, holistic approach. Recent efforts show promise in integrating harm reduction strategies. Encouraging collaboration between drug and tobacco harm reduction supporters is crucial for comprehensive support. Recognizing shared challenges can help create a united front transcending ideological differences.

May 21, 2025 by gfn.tv

GFN News #152 | PAKISTAN'S TOBACCO CONTROL PROBLEM | Can Pakistan get on track with tobacco harm reduction?

30 million people currently smoke in Pakistan, but could safer nicotine products such as nicotine pouches succeed where other tobacco control efforts have struggled? Joining us today is Ziauddin Islam, a tobacco control expert and former Technical Representative to the WHO FCTC and ITP, to highlight the direction of Pakistan's tobacco control efforts.

May 21, 2025 by news-medical.net

Pod-style electronic cigarettes found to be more addictive than nicotine gum

A study in Nicotine and Tobacco Research by Oxford University Press reveals that modern pod-style e-cigarettes are more addictive than nicotine gum, posing a high risk of abuse. These devices, favored by youth, deliver nicotine efficiently, especially to non-smokers. Researchers compared pod-style e-cigarettes to nicotine gum in nonsmoking young adults and found e-cigarettes more satisfying and craving-reducing. The appeal of these devices lies in the use of nicotine salts, which lessen the unpleasant taste of higher nicotine levels. The study emphasizes the addictive potential of e-cigarettes, particularly among inexperienced users like youth and young adults, prompting caution.

May 21, 2025 by news-medical.net

Pod-style electronic cigarettes found to be more addictive than nicotine gum

A study in Nicotine and Tobacco Research by Oxford University Press reveals that modern pod-style e-cigarettes are more addictive than nicotine gum, posing a high risk of abuse. These devices, favored by youth, deliver nicotine efficiently, especially to non-smokers. Researchers compared pod-style e-cigarettes to nicotine gum in nonsmoking young adults and found e-cigarettes more satisfying and craving-reducing. The appeal of these devices lies in the use of nicotine salts, which lessen the unpleasant taste of higher nicotine levels. The study emphasizes the addictive potential of e-cigarettes, particularly among inexperienced users like youth and young adults, prompting caution.

May 19, 2025 by westernstandard.news

Young men, former smokers most likely to try nicotine pouches, new study shows

A study led by epidemiologist Amanda Palmer shows that young men and current tobacco users are most likely to use nicotine pouches, a new product in the tobacco industry. The research, based on data from 2022-23 Population Assessment of Tobacco and Health Survey, found this trend among almost 23,000 participants. Published in JAMA Network Open, this is one of the first studies to measure the popularity of nicotine pouches, starting with Wave 7 of the survey which began tracking tobacco use in 2013.

May 19, 2025 by nih.gov

Comparing smoking-related disease rates from e-cigarette use with those from tobacco cigarette use: a reanalysis of a recently-published study

A recent meta-analysis compared e-cigarette and smoking risks, finding dual use riskier. The accuracy of these conclusions was examined, focusing on heart attack, stroke, and lung disease. Some studies could have been excluded, but valid data showed reduced risks for vaping compared to smoking. Dual use posed higher risks. Bias affected conclusions, with limited unbiased data showing no significant vaping effects on diseases. The original meta-analysis had bias issues and switching to e-cigarettes might reduce disease risk. More unbiased studies are needed to support conclusions drawn by Glantz et al. on vaping risks.

May 19, 2025 by springer.com

Inaccurate and misleading meta-analysis of E-cigarettes and population-based diseases

The text criticizes Glantz et al.'s meta-analysis on disease outcomes related to e-cigarette use. The study inaccurately classified diseases, including irrelevant outcomes such as erectile dysfunction and influenza, leading to a biased interpretation. Glantz et al. mixed outcomes in cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) categories, lacked justification for outcome selection, and included studies with poor research design. The use of cross-sectional data without key information and inadequate adjustments in longitudinal studies further compromised the validity of the analysis. The study concludes that the pooled odds ratio was inflated due to these shortcomings.

May 19, 2025 by vapingpost.com

Flawed Science, Fatal Consequences: Unpacking the Misinformation War on Vaping

Scientific evidence challenges old views on tobacco control, particularly regarding safer nicotine alternatives like e-cigarettes and nicotine pouches. The debate questions if these alternatives aid smoking cessation or create new nicotine users. Critiques reveal major flaws in prominent anti-vaping research, casting doubt on its credibility and impact on policy-making. Encouraging harm reduction, groups advocate for evidence-based regulation instead of moral panic. Success stories in countries like Sweden demonstrate reduced smoking rates through harm reduction strategies. Despite mounting evidence, some nations persist in restrictive regulations, risking progress in smoking cessation. It's time for public health leaders to embrace harm reduction and dismiss flawed research hindering societal health gains.

May 16, 2025 by filtermag.org

A Health Philosopher’s Views on Tobacco Harm Reduction

The tobacco harm reduction (THR) debate raises ethical questions about misinformation, youth rights, and health equity. Dr. Sridhar Venkatapuram explores these issues, advocating for harm reduction strategies over bans and discussing the societal factors influencing smoking. He emphasizes providing accurate information, supporting marginalized populations, and balancing individual freedoms with public health concerns. Venkatapuram addresses misconceptions around safer nicotine products, highlighting the complexities of regulating disposables and flavored vapes. He debates the role of tobacco companies in harm reduction efforts and advocates for individual autonomy in drug usage while acknowledging societal responsibilities. Venkatapuram advocates for a nuanced approach to addressing drug use and health disparities.

May 16, 2025 by rstreet.org

Beyond Nicotine Replacement Therapy: Smoking Cessation for Older Americans

Smoking is a major issue among older Americans, with higher rates of smoking and lower quit attempts compared to younger individuals. Nicotine Replacement Therapy (NRT) is effective in aiding smoking cessation, but older smokers face barriers such as cost and access. Combining NRT with Cognitive Behavioral Therapy (CBT) and social support can enhance quitting success. Additionally, promoting non-combustible nicotine products like e-cigarettes can offer alternative quitting methods. To support smoking cessation among older Americans, tailored education, accessible resources, and policy interventions are crucial to increase awareness and decrease environmental triggers. Providing a variety of cessation options is essential for improving the health outcomes of older smokers.